Immunic Balance Sheet Health
Financial Health criteria checks 6/6
Immunic has a total shareholder equity of $28.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $54.3M and $25.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$46.67m |
Equity | US$28.93m |
Total liabilities | US$25.37m |
Total assets | US$54.30m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 10VA's short term assets ($52.5M) exceed its short term liabilities ($24.7M).
Long Term Liabilities: 10VA's short term assets ($52.5M) exceed its long term liabilities ($639.0K).
Debt to Equity History and Analysis
Debt Level: 10VA is debt free.
Reducing Debt: 10VA has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 10VA has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 10VA is forecast to have sufficient cash runway for 7 months based on free cash flow estimates, but has since raised additional capital.